Mission accomplished: NASA doctor receives personalized leukemia treatment
Summer 2015
The Summer 2015 issue of Conquest features stories about preventive action being taken by women who’ve inherited elevated cancer risks, the importance of palliative care, the Moon Shots Program’s research platforms and much more.
Jenna Arnold is reducing risk while...
Like most parents, Jenna Arnold is doing all she can to ensure that she’ll live a long life to see her son, Jack, grow up and pursue his dreams. Women such as Arnold, who carry BRCA gene mutations, are participating in a first-in-the-nation MD Anderson clinical trial to reduce their risk of cancer while leaving menopause for later.
Blood test could reveal pancreatic cancer earlier
MD Anderson researchers believe they may have found a way to detect pancreatic cancer at an early stage, before it has spread to other...
Don’t let the sun catch you unprepared
To prevent skin cancer — the most common type of the disease — it’s important to be informed about the sun’s harmful effects and...
Harnessing a mushroom’s toxin to kill cancer
For some time, cancer researchers have considered alpha-amanitin, the toxin derived from “death cap” mushrooms, as a possible cancer...
Doctors from MD Anderson and Houston Methodist Hospital have performed what is believed to be the world’s first partial skull and...
Palliative care and hospice care aren’t synonymous. Palliative care is a branch of medicine that helps patients deal with the physical...
To better understand the Moon Shots Program, we offer a look at the 10 platforms that drive the research.
When they aren’t fighting cancer, these faculty and staff members are expressing themselves
The MD Anderson Cancer Network® allows the institution to collaborate with healthcare providers to provide MD Anderson’s model of...
Ten years after San Antonio businessman Red McCombs and his wife, Charline, made a transformative $30 million gift to MD Anderson,...
Mentors’ guidance is invaluable for young scientists and clinicians
Bree Sandlin’s inner strength and inner voice helped her conquer Stage III triple-negative breast cancer and Mount Kilimanjaro.
The FDA-approved lenvatinib is helping thyroid cancer patients who don’t respond to standard treatment
Previous Issues
View archives
Summer 2019
Dense breasts and cancer risk: What women need to know
Fall 2018
Celebrating a breakthrough discovery
Summer 2018
Leaving pain behind and looking ahead to life
Spring 2018
The p53 pioneer
Fall 2017
The hospital's heroes
Summer 2017
A growing area of study
Spring 2017
A dogged pursuit
Fall 2016
Big data, big results
Summer 2016
Building on success
Spring 2016
Family planning
Fall 2015
The cold virus versus cancer
Spring 2015
No patient left behind
Fall 2014
The cancer vaccine
Summer 2014
The game changer
Spring 2014
Plans to knock out tobacco
Fall 2013
Looking beyond the cancer cell
Summer 2013
A magnificent seven
Spring 2013
Moon shots program update
Fall 2012
MD Anderson's Moon Shots Program
Summer 2012
Where change begins
Spring 2012
The Pilots of the OR
Fall 2011
Changing the Stories We Tell
Summer 2011
Through Whirlwind and Calm
Spring 2011
Lungs That Function Not Taken for Granted
Fall 2010
Branching Out to Conquer Cancer
Summer 2010
Survivorship:
Spring 2010
Pathology: